Hybrid treatment of massive pulmonary embolism by catheter-directed and surgical embolectomy
Pulmonary embolism (PE) is a life-threatening disease, responsible for up to 300 000 deaths annually in the US, ranking among the leading causes of cardiovascular mortality [1]. Systemic thrombolytic therapy is recommended for patients with high-risk PE [2]. Yet, thrombolysis is contraindicated or...
Guardado en:
Autores principales: | Arkadiusz Pietrasik, Aleksandra Gąsecka, Mateusz Leśniewski, Dariusz Zieliński, Szymon Darocha, Marcin Kurzyna |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfd5c288acc34d69b3bba5d3b53689f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Surgical pulmonary embolectomy on VA-ECMO
por: Rachel Steinhorn, et al.
Publicado: (2021) -
One-day experience of pulmonary embolism response team (PERT) during the COVID-19 pandemic:
three urgent percutaneous pulmonary embolectomies
in acute pulmonary embolism
por: Andrzej Łabyk, et al.
Publicado: (2021) -
Embolectomy of acute embolic stroke associated with ipsilateral carotid web: a case report and literature review
por: JunTao Yin, et al.
Publicado: (2021) -
Hypocalcemia and massive pulmonary embolism in SLE patient with COVID‐19 infection: A case report
por: Mohammed Yousif Elnaeem Yousif, et al.
Publicado: (2021) -
Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Aneta Kacprzak, et al.
Publicado: (2021)